tm logo
KNOA PHARMA
Live/Pending
FIRST EXTENSION - GRANTED

granted

on 19 Dec 2023

Last Applicant/ Owned by

201 Tresser Boulevard

Stamford

CT

06901

Serial Number

97009389 filed on 02th Sep 2021

Registration Number

N/A

Correspondent Address

Fara S. Sunderji

DORSEY & WHITNEY LLP

51 WEST 52ND STREET

NEW YORK,NY 10019-6119

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

"PHARMA"

KNOA PHARMA

Pharmaceutical research and development "PHARMA" A house mark for a full line of pharmaceuticals; pharmaceuticals for use in the treatment of central nervous system disorders, pain, opioid overdose, opioid reversal, opioid use disorders, interstitial cystitis/bladder pain syndrome (IC/BPS), Overactive Bladder (OAB), Alcohol Use Disorder, Substance Use Disorder, sleep disorders including InsomniaRead More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Pharmaceutical research and development

Class [005]
Pharmaceutical Products


A house mark for a full line of pharmaceuticals; pharmaceuticals for use in the treatment of central nervous system disorders, pain, opioid overdose, opioid reversal, opioid use disorders, interstitial cystitis/bladder pain syndrome (IC/BPS), Overactive Bladder (OAB), Alcohol Use Disorder, Substance Use Disorder, sleep disorders including Insomnia Associated with Alcohol Cessation (IAAC), anaphylaxis; pharmaceuticals for use in the treatment of oncology conditions, specifically glioblastoma multiforme (GBM), non Hodgkin lymphoma, solid tumors, melanoma, chronic myelogenous leukemia, hemato-oncology, refractory/relapsed malignancies, alone or in combination with other agents; analgesics; pharmaceuticals, namely, opioid antagonists; syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; syringes filled with opioid antagonists; injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; injectors filled with opioid antagonists; injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; injectable pharmaceuticals, namely, opioid antagonists

Mark Details


Serial Number

No 97009389

Mark Type

No Service Mark

Attorney Docket Number

No 491396-00002

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
21st Dec 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
19th Dec 2023SOU TEAS EXTENSION RECEIVED
19th Dec 2023SOU EXTENSION 1 FILED
19th Dec 2023SOU EXTENSION 1 GRANTED
27th Jun 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02th May 2023PUBLISHED FOR OPPOSITION
02th May 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12th Apr 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27th Mar 2023APPROVED FOR PUB - PRINCIPAL REGISTER
16th Mar 2023EXAMINERS AMENDMENT -WRITTEN